Inactive Instrument

Other languages Soliton, Inc.

Equities

Soliton, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	13/21/13
Soliton, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/21/13
Soliton : AbbVie, Soliton Providing FTC Extra Time to Review Proposed Deal	03/21/03
Soliton, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	14/21/14
Sector Update: Health Care Stocks Hanging On For Modest Rise	11/21/11
Sector Update: Health Care Stocks Extending Monday Gains, Overcoming Biotech Weakness	10/21/10
AbbVie : Allergan Aesthetics to Acquire Soliton for $22.60 per Share	10/21/10
Soliton : 501k Application for RESONIC Device Accepted by FDA	15/21/15
Soliton : Initiates Second Animal Study for Potential Liver Fibrosis Treatment	09/21/09
Soliton, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2020	05/21/05
Soliton : Receives FDA Clearance of Rapid Acoustic Pulse Technology to Treat Cellulite; Shares Rise Pre-Bell	01/21/01
Soliton, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	12/20/12
Soliton : Names Brad Hauser Chief Executive; Shares Rise	02/20/02
Soliton, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	11/20/11

No results for this search